Comparison of artificial neural networks with other statistical approaches: Results from medical data setsSARGENT, Daniel J.Cancer. 2001, Vol 91, Num 8, pp 1636-1642, issn 0008-543X, SUPConference Paper

Counting degrees of freedom in hierarchical and other richly-parameterised modelsHODGES, James S; SARGENT, Daniel J.Biometrika. 2001, Vol 88, Num 2, pp 367-379, issn 0006-3444Article

Molecular Pathways: Microsatellite Instability in Colorectal Cancer: Prognostic, Predictive, and Therapeutic ImplicationsSINICROPE, Frank A; SARGENT, Daniel J.Clinical cancer research (Print). 2012, Vol 18, Num 6, pp 1506-1512, issn 1078-0432, 7 p.Article

A flexible design for multiple armed screening trialsSARGENT, Daniel J; GOLDBERG, Richard M.Statistics in medicine. 2001, Vol 20, Num 7, pp 1051-1060, issn 0277-6715Article

Designing a Randomized Clinical Trial to Evaluate Personalized Medicine: A New Approach Based on Risk PredictionBAKER, Stuart G; SARGENT, Daniel J.Journal of the National Cancer Institute. 2010, Vol 102, Num 23, pp 1756-1759, issn 0027-8874, 4 p.Article

Clinical trial designs for predictive Marker validation in cancer treatment trialsSARGENT, Daniel J; CONLEY, Barbara A; ALLEGRA, Carmen et al.Journal of clinical oncology. 2005, Vol 23, Num 9, pp 2020-2027, issn 0732-183X, 8 p.Article

Genetic evidence that two independent S-loci control RNase-based self-incompatibility in diploid strawberryBOSKOVIC, Radovan I; SARGENT, Daniel J; TOBUTT, Kenneth R et al.Journal of experimental botany. 2010, Vol 61, Num 3, pp 755-763, issn 0022-0957, 9 p.Article

Molecular Testing for Lymph Node Metastases as a Determinant of Colon Cancer Recurrence: Results from a Retrospective Multicenter StudySARGENT, Daniel J; QIAN SHI; WU, Tsung-Teh et al.Clinical cancer research (Print). 2014, Vol 20, Num 16, pp 4361-4369, issn 1078-0432, 9 p.Article

Associations Between Cigarette Smoking Status and Colon Cancer Prognosis Among Participants in North Central Cancer Treatment Group Phase III Trial N0147PHIPPS, Amanda I; QIAN SHI; NEWCOMB, Polly A et al.Journal of clinical oncology. 2013, Vol 31, Num 16, pp 2016-2023, issn 0732-183X, 8 p.Article

Comparison of Outcomes After Fluorouracil-Based Adjuvant Therapy for Stages II and III Colon Cancer Between 1978 to 1995 and 1996 to 2007: Evidence of Stage Migration From the ACCENT DatabaseQIAN SHI; ANDRE, Thierry; O'CONNELL, Michael J et al.Journal of clinical oncology. 2013, Vol 31, Num 29, pp 3656-3663, issn 0732-183X, 8 p.Article

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trialGROTHEY, Axel; VAN CUTSEM, Eric; ADENIS, Antoine et al.Lancet (British edition). 2013, Vol 381, Num 9863, pp 303-312, issn 0140-6736, 10 p.Article

Association of Obesity With DNA Mismatch Repair Status and Clinical Outcome in Patients With Stage II or III Colon Carcinoma Participating in NCCTG and NSABP Adjuvant Chemotherapy TrialsSINICROPE, Frank A; FOSTER, Nathan R; YOON, Harry H et al.Journal of clinical oncology. 2012, Vol 30, Num 4, pp 406-412, issn 0732-183X, 7 p.Article

Clinical Predictors of Severe Cetuximab-Induced Rash: Observations from 933 Patients Enrolled in North Central Cancer Treatment Group Study N0147JATOI, Aminah; GREEN, Erin M; ROWLAND, Kendrith M et al.Oncology. 2009, Vol 77, Num 2, pp 120-123, issn 0030-2414, 4 p.Article

Optimising the design of phase II oncology trials : The importance of randomisationRATAIN, Mark J; SARGENT, Daniel J.European journal of cancer (1990). 2009, Vol 45, Num 2, pp 275-280, issn 0959-8049, 6 p.Article

Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer : Results from intergroup N9741DY, Grace K; KROOK, James E; POCKAJ, Barbara A et al.Journal of clinical oncology. 2007, Vol 25, Num 23, pp 3469-3474, issn 0732-183X, 6 p.Article

Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST study group trial. DiscussionsFLESHMAN, James; SARGENT, Daniel J; ROTHENBERGER, David A et al.Annals of surgery. 2007, Vol 246, Num 4, pp 655-664, issn 0003-4932, 10 p.Conference Paper

A pilot study of high-dose intraarterial Cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patients with T3No-N3MO squamous cell carcinoma of the upper aerodigestive tractFOOTE, Robert L; KASPERBAUER, Jan L; OKUNO, Scott H et al.Cancer. 2005, Vol 103, Num 3, pp 559-568, issn 0008-543X, 10 p.Article

A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancerMARTENSON, James A; VIGLIOTTI, Antonio P. G; PITOT, Henry C et al.International journal of radiation oncology, biology, physics. 2003, Vol 55, Num 5, pp 1305-1310, issn 0360-3016, 6 p.Article

Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients With locally advanced colon cancerALLEGRA, Carmen J; PARR, Allyson L; KUGLER, John W et al.Journal of clinical oncology. 2002, Vol 20, Num 7, pp 1735-1743, issn 0732-183XArticle

Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal CancerSLOAN, Jeff A; GOLDBERG, Richard M; SARGENT, Daniel J et al.Journal of clinical oncology. 2002, Vol 20, Num 6, pp 1491-1498, issn 0732-183XArticle

Evaluation of Alternate Categorical Tumor Metrics and Cut Points for Response Categorization Using the RECIST 1.1 Data WarehouseMANDREKAR, Sumithra J; AN, Ming-Wen; MEYERS, Jeffrey et al.Journal of clinical oncology. 2014, Vol 32, Num 8, pp 841-850, issn 0732-183X, 10 p.Article

Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from U.S. Cooperative Oncology GroupsSCHROEN, Anneke T; PETRONI, Gina R; DJULBEGOVIC, Benjamin et al.Clinical cancer research (Print). 2012, Vol 18, Num 1, pp 256-262, issn 1078-0432, 7 p.Article

Predictive biomarkers in colorectal cancer: usage, validation, and design in clinical trialsQIAN SHI; MANDREKAR, Sumithra J; SARGENT, Daniel J et al.Scandinavian journal of gastroenterology. 2012, Vol 47, Num 3, pp 356-362, issn 0036-5521, 7 p.Article

Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon CancerSARGENT, Daniel J; MARSONI, Silvia; RIBIC, Christine et al.Journal of clinical oncology. 2010, Vol 28, Num 20, pp 3219-3226, issn 0732-183X, 8 p.Article

Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: A pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trialsJATOI, Aminah; FOSTER, Nathan R; EGNER, James R et al.International journal of oncology. 2010, Vol 36, Num 3, pp 601-606, issn 1019-6439, 6 p.Article